TRPV1 - transient receptor potential cation channel subfamily V member 1 Gene

Species: Felis catus

Gene Type: protein coding
Gene ID: 101093406

TRPV1 Products (10)

mRNA Protein Name
XM_045044056.1 XP_044899991.1 transient receptor potential cation channel subfamily V member 1 isoform X1
XM_045044057.1 XP_044899992.1 transient receptor potential cation channel subfamily V member 1 isoform X1
XM_019817317.3 XP_019672876.1 transient receptor potential cation channel subfamily V member 1 isoform X1
XM_023244721.2 XP_023100489.1 transient receptor potential cation channel subfamily V member 1 isoform X1
XM_045044054.1 XP_044899989.1 transient receptor potential cation channel subfamily V member 1 isoform X1
XM_003996390.6 XP_003996439.1 transient receptor potential cation channel subfamily V member 1 isoform X1
XM_045044053.1 XP_044899988.1 transient receptor potential cation channel subfamily V member 1 isoform X1
XM_045044059.1 XP_044899994.1 transient receptor potential cation channel subfamily V member 1 isoform X3
XM_045044060.1 XP_044899995.1 transient receptor potential cation channel subfamily V member 1 isoform X4
XM_045044058.1 XP_044899993.1 transient receptor potential cation channel subfamily V member 1 isoform X2
Protein Preferred Names Protein Names

transient receptor potential cation channel subfamily V member 1

  • transient receptor potential channel vanilloid subfamily member-1

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (3)
Art. -Nr. Produktname Wirkung
Reinheit Rare Diseases
HY-16413 Protokylol hydrochloride Agonist 99.07% Unkown
HY-A0191 Dexbrompheniramine Antagonist 99.93% Unkown
HY-124073 Dihydrocapsiate Agonist 99.33% Unkown

Clinical Phase

Bioactive Molecules (6)
Art. -Nr. Produktname Wirkung
Reinheit Phase
HY-132596A Tivanisiran sodium Inhibitor 96.85% Phase 3
HY-118785 MSP-3 Agonist 98.53% Phase 2
HY-12914 V116517 Antagonist / Phase 2
HY-19589 JTS-653 Antagonist / Phase 2
HY-N8377 Capsiate Agonist 99.85% Phase 1
HY-P10762 Ricorfotide vedotin Ligand 98.45% Phase 1

Pre-clinical Phase

Bioactive Molecules (47)
Art. -Nr. Produktname
Wirkung
Reinheit
Rare Diseases
HY-10863 Anandamide Activator ≥99.0% Unkown
HY-12245 SB-366791 Antagonist 99.29% Unkown
HY-N0361 Dihydrocapsaicin Agonist 99.93% Unkown
HY-120691A GSK205 Antagonist 99.47% Unkown
HY-107436 LE135 Activator 99.0% Unkown
HY-108448 N-Oleoyldopamine Agonist 99.47% Unkown
HY-101323 Olvanil Agonist ≥99.0% Unkown
HY-N8264 Moringin Agonist 99.95% Unkown
HY-100129 JNJ-17203212 Antagonist 99.44% Unkown
HY-N5084 Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside Antagonist 98.92% Unkown
HY-N0637A (±)-Eriodictyol Inhibitor 99.9% Unkown
HY-136363 MDR-652 Agonist 98.08% Unkown
HY-110018 N-Arachidonyldopamine Activator 98.36% Unkown
HY-144372 TRPV1 antagonist 3 Antagonist 99.30% Unkown
HY-101389 (R)-Methanandamide Agonist 99.61% Unkown
HY-N7144A Citronellyl acetate 98.0% Unkown
HY-103333 Arvanil Agonist 99.1% Unkown
HY-120962 N-Arachidonoyl Taurine Activator 99.0% Unkown
HY-120294 Chrysin 6-C-glucoside 8-C-arabinoside Inhibitor 98.55% Unkown
HY-185011 AM9053 Activator 98.36% Unkown
HY-103325 JTE-907 Activator 98.54% Unkown
HY-114017 Libvatrep Antagonist 99.54% Unkown
HY-172774 TRPV1 antagonist 10 Antagonist 98.54% Unkown
HY-W014394 Vanillyl butyl ether Agonist 99.75% Unkown
HY-10635 ABT-102 Antagonist 98.50% Unkown
HY-P1175 L-R4W2 Antagonist 98.13% Unkown
HY-W790266 Polygodial pyridazine Agonist / Unkown
HY-162908 TRPV1/CB2 agonist 1 Agonist / Unkown
HY-167160 AZ12099548 Antagonist / Unkown
HY-P11022 TL-119 Inhibitor / Unkown
HY-106427 SA-13353 Agonist / Unkown
HY-115133 ABT-116 Antagonist / Unkown
HY-108459 6-Iodonordihydrocapsaicin Antagonist / Unkown
HY-111218 TRPV1 antagonist 5 Antagonist / Unkown
HY-182517 AG1529 Antagonist / Unkown
HY-156959 Ovalicin Inhibitor / Unkown
HY-105324 GRC-6211 Antagonist / Unkown
HY-157766 FAAH/TRPV1 blocker-1 Inhibitor / Unkown
HY-P1175A L-R4W2 TFA Antagonist / Unkown
HY-W517163 MK-2295 Antagonist / Unkown
HY-165459 KJM429 Modulator / Unkown
HY-114583 AMG-8562 Modulator / Unkown
HY-176063 TRPV1 antagonist 11 Antagonist / Unkown
HY-N12639 β-Sanshool Activator / Unkown
HY-183857 DD-161515 Inhibitor / Unkown
HY-N11077 4,5-Di-O-caffeoylquinic acid Activator 98% Unkown
HY-181463 20-Hydroxy-N-arachidonoyl taurine Activator / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens TRPV1 NCBI NCBI:7442